tirzepatide pill vs shot GLP-1 Pills Shots: Which One Actually Works Better? Tirzepatide vs. Semaglutide for Weight

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials [published correction appears in Lancet Diabetes Endocrinol

Recent clinical trials show that GLP-1/GIP dual agonists can significantly improve body weight, fasting and after-meal blood glucose levels, insulin sensitivity, and total cholesterol

In females, L2-Cmu mAb treatment led to a slight, albeit significant reduction in red blood cells (RBCs), hemoglobin (Hb), hematocrit (Hct), white blood cells (WBCs), lymphocytes (Supplementary Table 2), and serum phosphorus (Supplementary Table 3), though most values, with the exception of WBCs, remained within the normal range, and were less severely affected than previously reported with Ganitumab in young CD1 mice 26

If each 0.1 mL spray must contain 100 mcg, then 1 mL of solution must contain 1,000 mcg

Almashhadany et al., 2022

The same question for tirzepatide (Mounjaro, Zepbound) has a different answer because the FDA guidance for those drugs requires a longer 72-hour minimum, not 48 hours